3BBT

crystal structure of the ErbB4 kinase in complex with lapatinib


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.8 Å
  • R-Value Free: 0.289 
  • R-Value Work: 0.251 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Mechanism of Activation and Inhibition of the HER4/ErbB4 Kinase.

Qiu, C.Tarrant, M.K.Choi, S.H.Sathyamurthy, A.Bose, R.Banjade, S.Pal, A.Bornmann, W.G.Lemmon, M.A.Cole, P.A.Leahy, D.J.

(2008) Structure 16: 460-467

  • DOI: 10.1016/j.str.2007.12.016
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • HER4/ErbB4 is a ubiquitously expressed member of the EGF/ErbB family of receptor tyrosine kinases that is essential for normal development of the heart, nervous system, and mammary gland. We report here crystal structures of the ErbB4 kinase domain i ...

    HER4/ErbB4 is a ubiquitously expressed member of the EGF/ErbB family of receptor tyrosine kinases that is essential for normal development of the heart, nervous system, and mammary gland. We report here crystal structures of the ErbB4 kinase domain in active and lapatinib-inhibited forms. Active ErbB4 kinase adopts an asymmetric dimer conformation essentially identical to that observed to be important for activation of the EGF receptor/ErbB1 kinase. Mutagenesis studies of intact ErbB4 in Ba/F3 cells confirm the importance of this asymmetric dimer for activation of intact ErbB4. Lapatinib binds to an inactive form of the ErbB4 kinase in a mode equivalent to its interaction with the EGF receptor. All ErbB4 residues contacted by lapatinib are conserved in the EGF receptor and HER2/ErbB2, which lapatinib also targets. These results demonstrate that key elements of kinase activation and inhibition are conserved among ErbB family members.


    Organizational Affiliation

    Department of Biophysics & Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Receptor tyrosine-protein kinase erbB-4
B, D
328Homo sapiensMutation(s): 0 
Gene Names: ERBB4 (HER4)
EC: 2.7.10.1
Find proteins for Q15303 (Homo sapiens)
Go to Gene View: ERBB4
Go to UniProtKB:  Q15303
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
FMM
Query on FMM

Download SDF File 
Download CCD File 
B, D
N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE
C29 H26 Cl F N4 O4 S
BCFGMOOMADDAQU-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
FMMIC50: 347 - >1000 nM (100) BINDINGDB
FMMKd: 54 nM (100) BINDINGDB
FMMKi: 700 nM PDBBIND
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.8 Å
  • R-Value Free: 0.289 
  • R-Value Work: 0.251 
  • Space Group: P 61
Unit Cell:
Length (Å)Angle (°)
a = 102.682α = 90.00
b = 102.682β = 90.00
c = 185.124γ = 120.00
Software Package:
Software NamePurpose
DENZOdata reduction
SCALEPACKdata scaling
REFMACrefinement
PHASERphasing
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2007-11-11 
  • Released Date: 2008-02-12 
  • Deposition Author(s): Qiu, C.

Revision History 

  • Version 1.0: 2008-02-12
    Type: Initial release
  • Version 1.1: 2011-07-13
    Type: Advisory, Refinement description, Version format compliance
  • Version 1.2: 2017-10-25
    Type: Refinement description